Suppr超能文献

新型免疫抑制药物FK-506对小鼠B淋巴细胞增殖的抑制作用。

Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK-506.

作者信息

Walliser P, Benzie C R, Kay J E

机构信息

Biochemistry Laboratory, School of Biological Sciences, University of Sussex, Brighton.

出版信息

Immunology. 1989 Nov;68(3):434-5.

Abstract

The novel immunosuppressive drug FK-506 inhibits both cell-mediated and humoral immunity in vivo and suppresses T-lymphocyte activation at nanamolar concentrations in vitro. We report here that FK-506 also inhibits the in vitro proliferation of murine B lymphocytes induced by goat antimouse IgM (GaMIgM), although it does not affect the induction of proliferation by bacterial lipopolysaccharide (LPS). The action of FK-506 on B-lymphocyte proliferation thus resembles that of cyclosporin A, further strengthening the correlation between the action of the two immunosuppressive drugs previously reported for T-lymphocyte activation.

摘要

新型免疫抑制药物FK-506在体内可抑制细胞介导的免疫和体液免疫,并在体外以纳摩尔浓度抑制T淋巴细胞活化。我们在此报告,FK-506也可抑制山羊抗小鼠IgM(GaMIgM)诱导的小鼠B淋巴细胞的体外增殖,尽管它不影响细菌脂多糖(LPS)诱导的增殖。因此,FK-506对B淋巴细胞增殖的作用类似于环孢素A,进一步加强了先前报道的这两种免疫抑制药物对T淋巴细胞活化作用之间的相关性。

相似文献

7
Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses.
Immunopharmacology. 1990 Jul-Aug;20(1):57-61. doi: 10.1016/0162-3109(90)90007-2.

本文引用的文献

3
Cyclosporin as a probe for different modes of lymphocyte activation.
Ann Inst Pasteur Immunol. 1987 Jul-Aug;138(4):626-8. doi: 10.1016/s0769-2625(87)80135-6.
4
The cyclosporin-A-sensitive event in lymphocyte activation.淋巴细胞激活过程中对环孢素A敏感的事件。
Ann Inst Pasteur Immunol. 1987 Jul-Aug;138(4):622-5. doi: 10.1016/s0769-2625(87)80134-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验